Fibrinogen plasma concentration before delivery is not associated with postpartum haemorrhage: A prospective observational study

British Journal of Anaesthesia

Volumn 115, Issue 1, 2015, Pages 99-104

  Karlsson, O ^a   Jeppsson, A ^a,b   Thornemo, M ^a   Lafrenz, H ^c   Radstrom M ^d   Hellgren, M ^a,e,f  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Section of Rheumatology   (Sweden)

^d Department of Orthopaedics   (Sweden)

^e SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^f NONE   (Sweden)

Author keywords

delivery; fibrinogen; obstetric labor complications; postpartum hemorrhage

Indexed keywords

FIBRINOGEN; OXYTOCIN;

ADULT; ARTICLE; BLOOD SAMPLING; CESAREAN SECTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; INSTRUMENTAL DELIVERY; LABOR; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PLACENTAL DELIVERY; POSTPARTUM HEMORRHAGE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETAINED PLACENTA; SURGICAL SPONGE; UTERUS; VAGINAL DELIVERY; BLOOD; DELIVERY; PREGNANCY;

ADULT; DELIVERY, OBSTETRIC; FEMALE; FIBRINOGEN; HUMANS; POSTPARTUM HEMORRHAGE; PREGNANCY; PROSPECTIVE STUDIES;

EID: 84936761028     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aev039     Document Type: Article

References (25)

1. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers' Lives: Reviewingmaternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118(Suppl 1): 1-203
2. Lennox C. Scottish Confidential Audit of Severe Maternal Morbidity. In: 9th Annual Report, 2013
3. Al-Zirqi I, Vangen S, Forsen L, Stray-Pedersen B. Prevalence and risk factors of severe obstetric haemorrhage. BJOG 2008; 115: 1265-72
4. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch populationbased cohort study on standard (> or = 500 ml) and severe (> or = 1000 ml) postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2004; 115: 166-72
5. Biguzzi E, Franchi F, Ambrogi F, et al. Risk factors for postpartum hemorrhage in a cohort of 6011 Italian women. Thromb Res 2012; 129: e1-7
6. Butwick A, Carvalho B. The effect of colloid and crystalloid preloading on thromboelastography prior to Cesarean delivery. Can J Anaesth 2007; 54: 190-5
7. Levy JH,Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a reviewof critical levels and replacement therapy. Transfusion 2014; 54: 1389-405
8. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007; 5: 266-73
9. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth 2012; 108: 984-9
10. Karlsson O, Jeppsson A, Hellgren M. Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? Int J Obstet Anesth 2014; 23: 10-7
11. WHORecommendations for the Prevention and Treatment of Postpartum Haemorrhage. WHO Guidelines Approved by the Guidelines Review Committee. Geneva, 2012
12. Demidenko E. Sample size and optimal design for logistic regression with binary interaction. Stat Med 2008; 27: 36-46
13. MosessonMW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-904
14. Carling MS, Jeppsson A,Wessberg P, Henriksson A, Baghaei F, Brisby H. Preoperative fibrinogen plasma concentration is associated with perioperative bleeding and transfusion requirements in scoliosis surgery. Spine 2011; 36: 549-55
15. Walden K, Jeppsson A, Nasic S, Backlund E, Karlsson M. Low preoperative fibrinogen plasma concentration is associated with excessive bleeding after cardiac operations. Ann Thorac Surg 2014; 97: 1199-206
16. Hiippala ST, Myllyla GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5
17. Szecsi PB, Jorgensen M, Klajnbard A, Andersen MR, Colov NP, Stender S. Haemostatic reference intervals in pregnancy. Thromb Haemost 2010; 103: 718-27
18. Saha P, Stott D, Atalla R. Haemostatic changes in the puerperium '6weeks postpartum' (HIP Study)-implication formaternal thromboembolism. BJOG 2009; 116: 1602-12
19. Huissoud C, Carrabin N, Benchaib M, et al. Coagulation assessment by rotation thrombelastometry in normal pregnancy. Thromb Haemost 2009; 101: 755-61
20. Kjellberg U, Andersson NE, Rosen S, Tengborn L, Hellgren M. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81: 527-31
21. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth 2009; 102: 793-9
22. Peyvandi F, Biguzzi E, Franchi F, et al. Elevated prepartum fibrinogen levels are not associated with a reduced risk of postpartum hemorrhage. J Thromb Haemost 2012; 10: 1451-3
23. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009; 9: 55
24. Bonnar J, McNicol GP, Douglas AS. Coagulation and fibrinolytic mechanisms during and after normal childbirth. Br Med J 1970; 2: 200-3
25. Bonnar J, Prentice CR, McNicol GP, Douglas AS. Haemostatic mechanism in the uterine circulation during placental separation. Br Med J 1970; 2: 564-7